Cash on Hand for Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported cash and short-term investments is $9.13B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingCash on HandSwitch metric
Latest period
$9.13B
YoY change
-23.8%
5Y CAGR
-3.0%
Peak year (2017)
$41.68B
Latest annual
$9.13B
Cash on Hand history chart for Amgen (AMGN) from 1985 to 2025
Cash on Hand history table for Amgen (AMGN) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $9.13B | -23.8% | ||
| 2024 | $11.97B | +9.4% | ||
| 2023 | $10.94B | +17.6% | ||
| 2022 | $9.30B | +15.8% | ||
| 2021 | $8.04B | -24.5% | ||
| 2020 | $10.65B | +19.5% | ||
| 2019 | $8.91B | -69.6% | ||
| 2018 | $29.30B | -29.7% | ||
| 2017 | $41.68B | +9.4% | ||
| 2016 | $38.09B | +21.4% | ||
| 2015 | $31.38B | +16.1% | ||
| 2014 | $27.03B | +39.3% | ||
| 2013 | $19.40B | -19.4% | ||
| 2012 | $24.06B | +16.6% | ||
| 2011 | $20.64B | +18.5% | ||
| 2010 | $17.42B | +29.6% | ||
| 2009 | $13.44B | +40.7% | ||
| 2008 | $9.55B | +33.6% | ||
| 2007 | $7.15B | +13.9% | ||
| 2006 | $6.28B | +19.4% | ||
| 2005 | $5.25B | -9.5% | ||
| 2004 | $5.81B | +13.4% | ||
| 2003 | $5.12B | +9.8% | ||
| 2002 | $4.66B | +75.2% | ||
| 2001 | $2.66B | +31.3% | ||
| 2000 | $2.03B | +52.1% | ||
| 1999 | $1.33B | +562.9% | ||
| 1998 | $201.10M | -15.9% | ||
| 1997 | $239.10M | +41.2% | ||
| 1996 | $169.30M | +153.8% | ||
| 1995 | $66.70M | -68.4% | ||
| 1994 | $211.30M | +64.4% | ||
| 1993 | $128.50M | +39.7% | ||
| 1992 | $92.00M | -37.2% | ||
| 1991 | $146.50M | +310.4% | ||
| 1990 | $35.70M | — | ||
| 1988 | $20.70M | -80.4% | ||
| 1987 | $105.60M | +83.3% | ||
| 1986 | $57.60M | -13.5% | ||
| 1985 | $66.60M | — |
Cash on Hand values are taken from Amgen's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual cash and short-term investments for Amgen (AMGN) came in at $9.13B – declined 23.8% year-over-year.
Over 2020–2025 (5 years), Amgen cash and short-term investments expanded at a -3.0% compound annual rate, with a net decline across the window.
Amgen cash and short-term investments peaked at $41.68B in 2017; the latest annual figure is $9.13B in 2025 (78.1% below peak).
2017 marks the peak cash and short-term investments at $41.68B, with the historical low of $20.70M recorded in 1988.
Among 8 Healthcare peers, Amgen (AMGN) ranks 6th; the peer median for cash and short-term investments is $12.34B.
Amgen Cash on Hand by Year
Amgen Cash on Hand 2025: $9.13B
Amgen cash and short-term investments in 2025 was $9.13B, declined 23.8% below 2024.
Amgen Cash on Hand 2024: $11.97B
Amgen cash and short-term investments in 2024 was $11.97B, grew 9.4% from 2023.
Amgen Cash on Hand 2023: $10.94B
Amgen cash and short-term investments in 2023 was $10.94B, grew 17.6% from 2022.
Amgen Cash on Hand 2022: $9.30B
Amgen cash and short-term investments in 2022 was $9.30B, grew 15.8% from 2021.
Amgen Cash on Hand 2021: $8.04B
Amgen cash and short-term investments in 2021 was $8.04B.
See more financial history for Amgen (AMGN).
Sector peers — Cash on Hand
Companies in the same sector as Amgen, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $10.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Amgen's cash and short-term investments?
- Latest reported cash and short-term investments for Amgen (AMGN) is $9.13B (period ending December 31, 2025).
How has Amgen cash and short-term investments changed year-over-year?
- Amgen (AMGN) cash and short-term investments changed -23.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen cash and short-term investments?
- Amgen (AMGN) cash and short-term investments compound annual growth rate is -3.0% over the most recent 5 years available.
When did Amgen cash and short-term investments hit its highest annual value?
- Amgen cash and short-term investments reached its highest annual value of $41.68B in 2017.
What was Amgen cash and short-term investments in 2024?
- Amgen (AMGN) cash and short-term investments in 2024 was $11.97B.
What was Amgen cash and short-term investments in 2025?
- Amgen (AMGN) cash and short-term investments in 2025 was $9.13B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.